Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

An important point about the updated guidelines is the emphasis on individualized treatment of complicated UTIs, recognizing ...

Many younger professionals are finding luck launching careers in second-tier cities like Raleigh, Milwaukee and Birmingham, a ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

The Food and Drug Administration has authorized Juul's original vaporizer and flavored cartridges to remain on the U.S.

The sale represents Clever Culture’s fifth engagement with a leading pharma manufacturer, including AstraZeneca, Bristol Myers Squibb and Thermo Fisher. The company is due to report its Q4 FY25 ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

While Leerink still expects Zoetis to post revenue and earnings growth, it sees the pace decelerating as rivals like Elanco and Merck (NSE: PROR) gain share. The firm forecasts Zoetis EPS growth to ...

After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

Over the last nine months, four senators led by Sen. Dick Durbin (D-Ill.) have conducted an inquiry into the growing ...